Original ArticlesSelf-Reported Medication and Recreational Drug Effectiveness in Maladaptive DaydreamingRoss, Colin A. MD*; West, Melina PhD†; Somer, Eli PhD‡Author Information *The Colin A. Ross Institute for Psychological Trauma, Richardson, Texas †Department of Psychological Sciences, University of Connecticut, Storrs, Connecticut ‡School of Social Work, University of Haifa, Haifa, Israel. Send reprint requests to Colin A. Ross, MD, The Colin A. Ross Institute for Psychological Trauma, 1701 Gateway #349, Richardson, TX 75080. E-mail: email@example.com. Online date: November 5, 2019 The Journal of Nervous and Mental Disease: January 2020 - Volume 208 - Issue 1 - p 77-80 doi: 10.1097/NMD.0000000000001091 Buy Metrics Abstract Maladaptive daydreaming is a proposed disorder characterized by excessive daydreaming that causes subjective distress and/or interferes with function. The daydreaming involves complex inner worlds, characters, and plots that are understood by the person as fantasy, and the daydreaming may occupy many hours per day. The disorder has good reliability and validity in studies using a structured interview and a self-report measure developed for it. To date, no information on the responses of maladaptive daydreamers to either recreational or prescription drugs has been available. The authors obtained survey data from 202 participants who completed the Maladaptive Daydreaming Scale-16. The results indicated that this population has tried many different recreational drugs and has been prescribed many different psychotropic medications. Most of the participants reported little to no effect of drugs or medications on daydreaming, although tentative recommendations can be made in favor of prescribing antidepressants and against the use of marijuana for individuals with maladaptive daydreaming. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.